Skip to content
Lower risk Drug recall · FDA · Published October 10, 2025

QuVa Pharma Recalls R.E.C.K. Injection Due to Particulate Matter

QuVa Pharma recalls R.E.C.K. (Ropivacaine HCl, Epinephrine, Clonidine HCl, Ketorolac Tromethamine) in Sodium Chloride Solution for periarticular use due to particulate matter. This compounded drug may cause blockages if injected.

🇺🇸 FDA recall #D-0113-2026DrugQuVa Pharma ›
Take action

Contact the company

Recalling firmQuVa Pharma, Inc.1075 W Park One Dr Ste 100 · Sugar Land, TX 77478-2576
✎ GovInfoNow plain-language explainer

QuVa Pharma is recalling a specific compounded medication called R.E.C.K. for periarticular use. The product contains particulate matter, which could cause blockages if injected into the body. Read more at govinfonow.com/recall/31733-quva-pharma-recalls-r-e-c-k-injection-due-to.

Source Summary by GovInfoNow · govinfonow.com/recall/31733-quva-pharma-recalls-r-e-c-k-injection-due-to · Updated August 17, 2026 · FDA enforcement record: FDA #D-0113-2026

Cite this page

“QuVa Pharma Recalls R.E.C.K. Injection Due to Particulate Matter.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31733-quva-pharma-recalls-r-e-c-k-injection-due-to. Based on FDA recall #D-0113-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0113-2026%22&limit=1).

The FDA announced on Oct. 10, 2025, that QuVa Pharma, Inc. voluntarily recalled R.E.C.K. compounded drug syringes due to the presence of particulate matter. Owners should contact the company for a full refund.

How to tell if you have it

  • Brand: QuVa Pharma
  • Product: R.E.C.K. (Ropivacaine HCl, EPINEPHrine, CloNIDine HCl, and Ketorolac Tromethamine) in Sodium Chloride Solution
  • NDC: 70092-1433-50
  • Lot codes: 10149179 through 10152861 (see full list in record)
  • Volume: 50 mL syringe
  • Distribution: U.S. Nationwide

The hazard

The recall is due to the presence of particulate matter in the syringes. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show QuVa Pharma, Inc. has 9 other recalls on record since March 30, 2016. Other recent recalls of similar products include GE Healthcare Omnipaque 300 mg/mL Injection Recall: Particulate Matter Hazard (March 24, 2026) and Cipla Lanreotide Injection Recall: Particulate Matter Hazard (Jan. 2, 2026).

How to tell if you have this one

Check for the product name 'R.E.C.K.' (Ropivacaine HCl, Epinephrine, Clonidine HCl, and Ketorolac Tromethamine) in 50 mL syringes. The NDC code is listed as 70092-1433-50 with specific lot numbers and expiration dates provided in the recall notice.

  • Brand
    QuVa Pharma
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the NDC code (70092-1433-50) and lot numbers listed in the recall notice to confirm if your medication is affected.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “U.S. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 26 days after the firm started it.

1. Firm started the recall: Oct 10, 202512. FDA classified it Class II: Oct 27, 202523. Published in FDA’s Enforcement Report: Nov 5, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What should I do if I have this medication?

Check the NDC code and lot numbers listed in the recall notice to determine if your product is affected. If it is, stop using it and contact QuVa Pharma for further instructions.

Similar recalls

Other QuVa Pharma recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0113-2026 (October 10, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0113-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA